Renova Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: San Diego CA United States (2009)

Organization Overview

First Clinical Trial
2010
NCT00787059
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Renova Therapeutics